- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07489651
RE104-studie om säkerhet och effekt vid generaliserat ångestsyndrom
En randomiserad, dubbelblind, placebokontrollerad studie som utvärderar säkerheten och effekten av RE104 för injektion vid behandling av generaliserat ångestsyndrom
The purpose of this study is to determine if treatment with a single and/or repeat dose of RE104 for Injection reduces anxiety symptoms in participants with Generalized Anxiety Disorder (GAD) as compared to placebo.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Beräknad)
Fas
- Fas 2
Kontakter och platser
Studiekontakt
- Namn: Mark Pollack Chief Medical Officer, M.D.
- Telefonnummer: 1-888-880-REUN
- E-post: info@reunionneuro.com
Studieorter
-
-
Alabama
-
Birmingham, Alabama, Förenta staterna, 35209
- Rekrytering
- University of Alabama (UAB) Clinical Research Unit (CRU)
-
Kontakt:
- Seher Premani
- Telefonnummer: spremani@uab.edu
- E-post: spremani@uab.edu
-
-
Arizona
-
Gilbert, Arizona, Förenta staterna, 85234
- Rekrytering
- Lighthouse Psychiatry
-
Kontakt:
- Matt Longson
- Telefonnummer: 435-268-5800
- E-post: Contact@neosciclinicalresearch.com
-
-
Arkansas
-
Little Rock, Arkansas, Förenta staterna, 72211
- Rekrytering
- Preferred Research Partners, Inc.
-
Kontakt:
- Stacy Tierney
- Telefonnummer: 111 501-553-9987
- E-post: stierney@preferredresearchpartners.com
-
-
California
-
Garden Grove, California, Förenta staterna, 92845
- Rekrytering
- Collaborative Neuroscience Research, LLC
-
Kontakt:
- CNS Outreach Department
- Telefonnummer: 844-424-9494
- E-post: cns.outreach@cenexel.com
-
La Jolla, California, Förenta staterna, 92037
- Rekrytering
- Kadima Neuropsychiatry Institute
-
Kontakt:
- Angelica Lu
- Telefonnummer: 858-775-2053
- E-post: angelical@kadimanp.com
-
San Francisco, California, Förenta staterna, 94114
- Rekrytering
- Open Mind Therapeutics
-
Kontakt:
- Victoria Vega
- Telefonnummer: 415-906-7399
- E-post: victoria@openmindcollective.org
-
Santa Monica, California, Förenta staterna, 90404
- Rekrytering
- TRIP Clinic at Psychedelic Science Institute
-
Kontakt:
- Ashley Ramos
- E-post: trialadmin@psychedlicsci.com
-
-
Florida
-
Lauderhill, Florida, Förenta staterna, 33319
- Rekrytering
- Innovative Clinical Research, Inc.
-
Kontakt:
- Melissa Rodco
- Telefonnummer: 305-722-8444
- E-post: mrodco@segaltrials.com
-
Tampa, Florida, Förenta staterna, 33613
- Rekrytering
- University of South Florida
-
Kontakt:
- Genesis Estramera
- Telefonnummer: 813-974-1404
- E-post: gestramera@usf.edu
-
-
Georgia
-
Atlanta, Georgia, Förenta staterna, 30331
- Rekrytering
- Atlanta Center for Medical Research
-
Kontakt:
- Amber Tannahill
- Telefonnummer: 404-881-5800
- E-post: a.tannahill@cenexel.com
-
Decatur, Georgia, Förenta staterna, 30030
- Rekrytering
- CenExel iResearch, LLC
-
Kontakt:
- Michael Mahaffrey
- E-post: m.mahaffrey@cenexel.com
-
Norcross, Georgia, Förenta staterna, 30092
- Rekrytering
- Evergreen Clinical Trials
-
Kontakt:
- Stephen Wheeler
- Telefonnummer: 943-230-1385
- E-post: stephen@evergreenstrials.com
-
Savannah, Georgia, Förenta staterna, 31405
- Rekrytering
- CenExel iResearch, LLC
-
Kontakt:
- Michelle Lagares
- Telefonnummer: 912-744-0800
- E-post: M.Lagares@CenExel.com
-
-
Illinois
-
Chicago, Illinois, Förenta staterna, 60640
- Rekrytering
- Uptown Research Institute
-
Kontakt:
- Deborah Jones-Miller
- Telefonnummer: 117 773-989-8313
- E-post: Djones-miller@uptownresearch.com
-
-
Michigan
-
Novi, Michigan, Förenta staterna, 48377
- Rekrytering
- Henry Ford Medical Center - Columbus
-
Kontakt:
- Madeline Bross
- Telefonnummer: 248-344-7366
- E-post: mbross1@hfhs.org
-
-
Missouri
-
Saint Charles, Missouri, Förenta staterna, 63304
- Rekrytering
- Midwest Research Group
-
Kontakt:
- Lindsay vanWinkle
- Telefonnummer: 3 636-946-8032
- E-post: lvanwinkle@midwestresearchgroup.com
-
-
New Mexico
-
Albuquerque, New Mexico, Förenta staterna, 14624
- Rekrytering
- UNM Research Program Psychedelic Therapies
-
Kontakt:
- Hector Garcia
- Telefonnummer: 505-675-0582
- E-post: hecgarcia@salud.unm.edu
-
-
New York
-
New York, New York, Förenta staterna, 10016
- Rekrytering
- NYU-H+C Clinical and Translational Science Institute
-
Kontakt:
- Jillian Kelly
- Telefonnummer: 212-404-7764
- E-post: Jillian.kelly@nyulangone.org
-
-
North Carolina
-
Chapel Hill, North Carolina, Förenta staterna, 27514
- Rekrytering
- University of North Carolina at Chapel Hill
-
Kontakt:
- Julia Hoffman
- E-post: julia_hoffmann1@med.unc.edu
-
-
Ohio
-
North Canton, Ohio, Förenta staterna, 44720
- Rekrytering
- Neuro-Behavioral Clinical Research, Inc.
-
Kontakt:
- Crystal Blackford
- Telefonnummer: 330-493-1118
- E-post: cblackford@nb-cr.com
-
-
Oregon
-
Portland, Oregon, Förenta staterna, 97210
- Rekrytering
- Summit Headlands LLC
-
Kontakt:
- Tyler Leecing
- E-post: tyler.leecing@summitnetwork.com
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Förenta staterna, 19104
- Rekrytering
- University of Pennsylvania
-
Kontakt:
- Erin Blase
- Telefonnummer: 215-746-6419
- E-post: erin.blase@pennmedicine.upenn.edu
-
West Chester, Pennsylvania, Förenta staterna, 19380
- Indragen
- Suburban Research Associates
-
-
Texas
-
Austin, Texas, Förenta staterna, 78737
- Rekrytering
- Austin Clinical Trial Partners
-
Kontakt:
- Kara Chilek
- Telefonnummer: 512-521-0595
- E-post: studyinfo@austinCTP.com
-
Austin, Texas, Förenta staterna, 78759
- Rekrytering
- BioBehavioral Research Austion
-
Kontakt:
- Tracie Wesson
- Telefonnummer: 402-934-0044
- E-post: tracie.wesson@qcrnetwork.com
-
Plano, Texas, Förenta staterna, 75093
- Rekrytering
- Aim Trials, LLC
-
Kontakt:
- Sonia Prashar
- Telefonnummer: 214-856-2778
- E-post: sonia.prashar@aimtrials.com
-
-
Utah
-
Draper, Utah, Förenta staterna, 84020
- Rekrytering
- Cedar Clinical Research
-
Kontakt:
- Jane Bjorklund
- Telefonnummer: 801-369-4219
- E-post: jane.bjorklund@numinusnetwork.com
-
Orem, Utah, Förenta staterna, 84058
- Rekrytering
- Inner Space State Street
-
Kontakt:
- Janet Jimenez
- Telefonnummer: 801-871-5516
- E-post: apply@innerspaceresearch.com
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Has Generalized Anxiety Disorder as defined by DSM-5-TR
- If female is not pregnant or planning to become pregnant. If male is not planning to make a partner pregnant.
- Is willing and able to comply with the conditions and requirements of the study
Exclusion Criteria:
- Has a significant risk of suicide
- Has an active or medical history of bipolar disorder, schizophrenia, schizoaffective disorder, psychotic disorder and/or borderline personality disorder, or first-degree family history of psychosis or bipolar disorder
- Has other concurrent psychiatric disorders that is the primary disorder.
- Has other medically significant conditions rendering unsuitability for the study
- Has used or will need to use prohibited medications or therapies
- Has a known sensitivity or intolerance to study intervention or potential rescue medications
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Trippel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Placebo-jämförare: Placebo
A single subcutaneous injection of 0.9% sodium chloride for injection per dosing session |
Single-dose (Part A) or Repeat-dose (Part B), subcutaneous injection(s) of 0.9% sodium chloride for injection |
|
Experimentell: 30 mg RE104
A single subcutaneous injection of 30 mg RE104 for Injection per dosing session |
Single dose (Part A) or Repeat-dose (Part B), subcutaneous injection(s) of RE104 for Injection |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
RE104 when administered as a single 30 mg dose or as two 30 mg doses 3 weeks apart versus placebo change from Baseline at Week 4 in Hamilton Anxiety Rating Scale (HAM-A) total score
Tidsram: Week 4
|
The Hamilton Rating Scale for Anxiety (HAM-A) is a 14-item scale that is used to rate the severity of symptoms of anxiety. The total score ranges from 0-56 with higher scores representing greater severity of anxiety. |
Week 4
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
RE104 versus placebo changes in total score from baseline in Hamilton Anxiety Rating Scale (HAM-A)
Tidsram: Weeks 1, 2, 8 and 12
|
The Hamilton Rating Scale for Anxiety (HAM-A) is a 14-item scale that is used to rate the severity of symptoms of anxiety. The total score ranges from 0-56 with higher scores representing greater severity of anxiety. |
Weeks 1, 2, 8 and 12
|
|
RE104 versus placebo percentage of participants with HAM-A response (≥50% reduction in score from Baseline)
Tidsram: Weeks 1, 2, 4, 8 and 12
|
The Hamilton Rating Scale for Anxiety (HAM-A) is a 14-item scale that is used to rate the severity of symptoms of anxiety. The total score ranges from 0-56 with higher scores representing greater severity of anxiety. |
Weeks 1, 2, 4, 8 and 12
|
|
RE104 versus placebo percentage of participants with HAM-A remission (total score ≤7)
Tidsram: Day 1 and Weeks 1, 2, 4, 8 and 12
|
The Hamilton Rating Scale for Anxiety (HAM-A) is a 14-item scale that is used to rate the severity of symptoms of anxiety. The total score ranges from 0-56 with higher scores representing greater severity of anxiety. |
Day 1 and Weeks 1, 2, 4, 8 and 12
|
|
RE104 versus placebo change from Baseline at Weeks 1, 2, 4, 8, and 12 in Hospital Anxiety and Depression Scale (HADS) depression subscore
Tidsram: Weeks 1, 2, 4, 8 and 12
|
The Hospital Anxiety and Depression Scale (HADS) is a self-reported scale measure the severity of depression and anxiety in patients with comorbid medical conditions. The scale consists of 14 items (7 for anxiety and 7 for depression), with a score ranging between 0 and 21 for the anxiety and depression subscales. |
Weeks 1, 2, 4, 8 and 12
|
|
RE104 versus placebo incidence of treatment-emergent adverse events (TEAEs) by frequency, severity and seriousness.
Tidsram: From dosing through study completion (post-dose follow-up is for 12 weeks)
|
A treatment-emergent adverse event (TEAE) is defined as any unfavorable and unintended sign, symptom or disease temporally associated with the use of a study drug. |
From dosing through study completion (post-dose follow-up is for 12 weeks)
|
|
RE104 versus placebo change from Baseline in Montgomery-Åsberg Depression Rating Scale (MADRS) (Part B only)
Tidsram: Weeks 1, 2, 4, 8, and 12
|
The Montgomery-Åsberg Depression Rating Scale (MADRS) is a 10-item clinician rated scale measuring depression severity. The total score ranges from 0-60 with higher scores representing greater severity of depression. |
Weeks 1, 2, 4, 8, and 12
|
Samarbetspartners och utredare
Sponsor
Utredare
- Studierektor: Mark Pollack, M.D., Reunion Neuroscience Inc
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- RE104-203-GAD
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Data sharing will be consistent with the results submission policy of ClinicalTrials.gov.
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .